Mabwell (688062.SH, 02493.HK) is an innovation-driven biopharmaceutical company with end-to-end capabilities from drug discovery to commercialization. Consistent with our commitment to provide more effective and accessible therapies and innovative products, Mabwell has worked to fulfill global medical needs and bring life-changing solutions to patients.
